| CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ... Cancer research 76 (19), 5671-5682, 2016 | 538 | 2016 |
| 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis D Kanojia, MM Vaidya Oral oncology 42 (7), 655-667, 2006 | 359 | 2006 |
| CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling PK Lo, D Kanojia, X Liu, UP Singh, FG Berger, Q Wang, H Chen Oncogene 31 (21), 2614-2626, 2012 | 220 | 2012 |
| Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ... Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019 | 116 | 2019 |
| Dynamic in vivo SPECT imaging of neural stem cells functionalized with radiolabeled nanoparticles for tracking of glioblastoma SH Cheng, D Yu, HM Tsai, RA Morshed, D Kanojia, LW Lo, L Leoni, ... Journal of Nuclear Medicine 57 (2), 279-284, 2016 | 82 | 2016 |
| Sui generis: gene therapy and delivery systems for the treatment of glioblastoma JR Kane, J Miska, JS Young, D Kanojia, JW Kim, MS Lesniak Neuro-oncology 17 (suppl_2), ii24-ii36, 2015 | 75 | 2015 |
| FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis A Cordero, D Kanojia, J Miska, WK Panek, A Xiao, Y Han, N Bonamici, ... Oncogene 38 (37), 6445-6460, 2019 | 69 | 2019 |
| βIII-Tubulin regulates breast cancer metastases to the brain D Kanojia, RA Morshed, L Zhang, JM Miska, J Qiao, JW Kim, P Pytel, ... Molecular cancer therapeutics 14 (5), 1152-1161, 2015 | 61 | 2015 |
| Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy X Liu, S Johnson, S Liu, D Kanojia, W Yue, UP Singh, Q Wang, Q Wang, ... Scientific reports 3 (1), 2473, 2013 | 60 | 2013 |
| Keratins: markers of cell differentiation or regulators of cell differentiation? MM Vaidya, D Kanojia Journal of biosciences 32 (4), 629-634, 2007 | 57 | 2007 |
| Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model E Rincón, T Cejalvo, D Kanojia, A Alfranca, MÁ Rodríguez-Milla, ... Oncotarget 8 (28), 45415, 2017 | 55 | 2017 |
| Intranasal oncolytic virotherapy with CXCR4-enhanced stem cells extends survival in mouse model of glioma M Dey, D Yu, D Kanojia, G Li, M Sukhanova, DA Spencer, KC Pituch, ... Stem Cell Reports 7 (3), 471-482, 2016 | 54 | 2016 |
| Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice D Kanojia, W Zhou, J Zhang, C Jie, PK Lo, Q Wang, H Chen PROTEOMICS, 2012 | 54 | 2012 |
| Neural stem cells secreting anti-HER2 antibody improve survival in a preclinical model of HER2 overexpressing breast cancer brain metastases D Kanojia, IV Balyasnikova, RA Morshed, RT Frank, D Yu, L Zhang, ... Stem Cells 33 (10), 2985-2994, 2015 | 51 | 2015 |
| Landscape of combination therapy trials in breast cancer brain metastasis J Fares, D Kanojia, A Rashidi, I Ulasov, MS Lesniak International journal of cancer 147 (7), 1939-1952, 2020 | 37 | 2020 |
| Genes that mediate metastasis across the blood–brain barrier J Fares, D Kanojia, A Rashidi, I Ulasov, MS Lesniak Trends in cancer 6 (8), 660-676, 2020 | 34 | 2020 |
| GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma A Rashidi, J Miska, C Lee-Chang, D Kanojia, WK Panek, A Lopez-Rosas, ... Cancer Immunology, Immunotherapy 69, 81-94, 2020 | 34 | 2020 |
| Diagnostic clinical trials in breast cancer brain metastases: barriers and innovations J Fares, D Kanojia, A Rashidi, AU Ahmed, IV Balyasnikova, MS Lesniak Clinical breast cancer 19 (6), 383-391, 2019 | 28 | 2019 |
| The network of cytokines in brain metastases J Fares, A Cordero, D Kanojia, MS Lesniak Cancers 13 (1), 142, 2021 | 26 | 2021 |
| Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma WK Panek, JR Kane, JS Young, A Rashidi, JW Kim, D Kanojia, ... Oncotarget 8 (51), 89391, 2017 | 26 | 2017 |
Jawad FaresNorthwestern UniversityDirección de correo verificada de northwestern.edu
